J&J unlikely to meet US vaccine supply goal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Johnson & Johnson will unlikely to meet the US COVID-19 vaccine supply target by spring, as the company faces delays in vaccine production, according to the New York Times report seen on Wednesday.

Actual Topics